Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;222(9):e20240677.
doi: 10.1084/jem.20240677. Epub 2025 Jul 7.

Adipose tissue harbors pathogenic T cells in obesity that exacerbate inflammatory arthritis

Affiliations

Adipose tissue harbors pathogenic T cells in obesity that exacerbate inflammatory arthritis

Heather J Faust et al. J Exp Med. .

Abstract

Obesity worsens inflammatory arthritis severity, even in non-load-bearing joints, but the mechanism is unknown. Here, we show that there is an immunological mechanism mediated by T cells in adipose tissue. Using an antigen-induced arthritis model with trackable, arthritis-inducing CD8+ OT-I T cells, we found that OT-I T cells home to visceral adipose tissue (VAT) and expand there in the obese high-fat diet (HFD) context. Transplant of VAT from arthritic mice increased arthritis severity in naïve recipient mice and was ameliorated by CD8 T cell depletion. Bulk RNA sequencing identified pro-inflammatory changes to OT-I T cells in VAT characterized by increased IFN α and γ signaling after HFD. Intraperitoneal injection of IFNα, but not IFNγ, expanded CD8 T cell numbers in VAT. HFD-induced expansion of VAT CD8 T cells was ameliorated with global Ifnar1 deletion, and importantly, genetic deletion of Ifnar1 in T cells decreased arthritis severity in obese mice. These results provide a mechanistic explanation of how obesity worsens autoimmunity.

PubMed Disclaimer

Conflict of interest statement

Disclosures: L. Lynch reported personal fees from Science Advances and Faeth Therapeutics outside the submitted work. P.A. Nigrovic reported grants from BMS, personal fees from Merck, Pfizer, Novartis, Sobi, Fresh Tracks Bio, Apollo, Alkermes, Century Therapeutics, Monte Rosa, and Simcere, and other from Edelweiss Immune outside the submitted work. M.B. Brenner reported personal fees from AbbVie and Moderna, other from Mestag Therapeutic, and grants from Johnson & Johnson and Ono Pharma outside the submitted work; in addition, M.B. Brenner had a patent to Granzyme K inflammation pending. No other disclosures were reported.

References

    1. Agere, S.A., Akhtar N., Watson J.M., and Ahmed S.. 2017. RANTES/CCL5 induces collagen degradation by activating MMP-1 and MMP-13 expression in human rheumatoid arthritis synovial fibroblasts. Front. Immunol. 8:1341. 10.3389/fimmu.2017.01341 - DOI - PMC - PubMed
    1. Alivernini, S., Tolusso B., Gigante M.R., Petricca L., Bui L., Fedele A.L., Di Mario C., Benvenuto R., Federico F., Ferraccioli G., and Gremese E.. 2019. Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis. Sci. Rep. 9:10420. 10.1038/s41598-019-46927-w - DOI - PMC - PubMed
    1. Allard, C., Miralpeix C., López-Gambero A.J., and Cota D.. 2024. mTORC1 in energy expenditure: Consequences for obesity. Nat. Rev. Endocrinol. 20:239–251. 10.1038/s41574-023-00934-0 - DOI - PubMed
    1. Alzabin, S., and Williams R.O.. 2011. Effector T cells in rheumatoid arthritis: Lessons from animal models. FEBS Lett. 585:3649–3659. 10.1016/j.febslet.2011.04.034 - DOI - PubMed
    1. Arai, K., Yamamura S., Hanyu T., Takahashi H.E., Umezu H., Watanabe H., and Abo T.. 1996. Extrathymic differentiation of resident T cells in the joints of mice with collagen-induced arthritis. J. Immunol. 157:5170–5177. - PubMed

MeSH terms

Substances